Thursday, October 15, 2026

North American Launches Growth-Focused Index for Fixed Annuities to Boost Portfolio Diversification

North American Company, one of the largest U.S. fixed index annuity issuers, added a new growth-focused index to its Secure Horizon FIA product line. The index shows low correlation to existing portfolio options, expanding diversification opportunities for agents and clients. The move reflects broader industry transformation through product innovation and capital efficiency strategies.

Source Trace Score10 source documents10 with a live linkVerifiability: High
North American Launches Growth-Focused Index for Fixed Annuities to Boost Portfolio Diversification
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

North American Company for Life and Health Insurance launched a new index option for its Secure Horizon fixed index annuities, adding a growth-focused benchmark with low correlation to its existing index portfolio. North American ranks among the largest U.S. issuers of fixed index annuities.

Tom Haines, a company representative, said the index enhances diversification opportunities for agents and clients. The growth-oriented index complements existing options in the portfolio due to its low correlation characteristics.

Fixed index annuities link returns to market index performance while providing principal protection. The products have gained traction as investors seek growth potential without full market exposure. Product innovation in index selection allows insurers to differentiate offerings and capture market share in a competitive landscape.

The annuity sector is undergoing strategic shifts through three channels: new product development, portfolio optimization via acquisitions and divestitures, and reinsurance restructuring. These moves aim to improve capital efficiency and generate stronger cash flows.

Competitors including F&G and other major players are pursuing similar strategies. Several insurers have increased dividends recently, signaling confidence in cash generation from optimized operations. The industry's focus on capital efficiency comes as regulatory frameworks evolve and interest rate environments shift.

Index-linked products require careful management of hedging costs and crediting strategies. Insurers balance attractive crediting rates for customers against capital requirements and profitability targets. The addition of low-correlation indices helps manage this balance by diversifying underlying exposure.

Strategic consolidation continues reshaping the market. Larger players acquire blocks of business to achieve scale efficiencies, while divesting non-core segments. This portfolio optimization drives improved returns on equity and frees capital for growth initiatives.

The transformation reflects broader insurance sector trends toward specialized products, data-driven pricing, and capital-light business models. Companies that successfully execute product innovation alongside operational efficiency are gaining competitive advantages in attracting both distribution partners and end customers.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score10 source documents10 with a live linkVerifiability: High
  1. [1]News articleYahoo Finance· December 23, 2025
    North American® and Annexus launch new Index with Deutsche Bank and ICE Data Indices for the Secure Horizon Fixed Index Annuity suite
  2. [2]News articleYahoo Finance· February 10, 2026
    539 Merrill Advisors Recognized on Forbes' Top Women Wealth Advisor Lists
  3. [3]Press releaseGlobeNewswire· February 3, 2026
    Brandon Hall Group Prepared to Host 2026 HCM Excellence Conference Next Week
  4. [4]Earnings callYahoo Finance· February 13, 2026
    Credicorp Q4 Earnings Call Highlights
  5. [5]Press releaseGlobeNewswire· February 4, 2026
    Europe and North America Home and Small Business Security System Market Report 2026: DIY Convergence, AI Integration, and Smart Home Competition Reshape the Landscape - Forecast to 2031
  6. [6]News articleSeeking Alpha· February 20, 2026
    F&G signals shift toward 25% fee-based earnings by 2028 while expanding AUM and capital flexibility
  7. [7]News articleYahoo Finance· December 3, 2025
    IGM FINANCIAL INC. ANNOUNCES NOVEMBER 2025 ASSETS UNDER MANAGEMENT & ADVISEMENT AND NET FLOWS
  8. [8]Press releaseGlobeNewswire· February 3, 2026
    Quantum Computing Market to Grow at Over 30% CAGR Through 2031 Driven by Government Funding, Enterprise Adoption, and Advances in High-Performance Computing | Astute Analytica
  9. [9]News articleYahoo Finance· February 24, 2026
    TBC Bank Group Investor Day: Targets 15%+ Loan Growth, 23%+ ROE and Teases Uzbekistan IPO Option
  10. [10]News articleYahoo Finance· February 11, 2026
    TPG Calls 2025 a “Breakout Year” at BofA Conference, Targets Another $50B+ Fundraising Year
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com